Advancing Cardiovascular Therapy: Frontiers in Cardiovascular Drug Discovery (Volume 6)

The Frontiers in Cardiovascular Drug Discovery book series is a pioneering initiative dedicated to publishing the latest breakthroughs in cardiovascular drug design and discovery. This esteemed series provides a comprehensive platform for medicinal chemists and pharmaceutical scientists to explore the most recent advances in preclinical and clinical research in cardiology.

Volume 6: Unveiling Cutting-Edge Research in Cardiovascular Therapy

This latest installment in the series presents an in-depth exploration of the following topics:

• Cardiovascular Effects of Ranolazine: A Review of the Latest Findings and Translational Research Opportunities
• Rho/Rho Kinase Signaling Pathway: Understanding the Complexities of Cardiovascular Disease
• The Challenges of Cardiovascular Drug Development: Hibernation or Transformation?
• Innovative Approaches to P2Y12 Receptor Blocker Drugs: Future Directions
• The Biochemical and Molecular Links between Diabetes and Cardiovascular Diseases

Published by Bentham Science Publishers on November 11, 2022, this 254-page paperback volume is an indispensable resource for researchers and scientists in the field of cardiovascular medicine. The ISBN-10 is 9815036920, and the ISBN-13 is 978-9815036923.

Stay ahead of the curve in cardiovascular research with Frontiers in Cardiovascular Drug Discovery, the premier book series for those dedicated to advancing the field.